to manufacture pathogen reduced blood components (Cerus Inc)
90
Structured Review
Cerus Inc
to manufacture pathogen reduced blood components
To Manufacture Pathogen Reduced Blood Components, supplied by Cerus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/to+manufacture+pathogen+reduced+blood+components/to+manufacture+pathogen+reduced+blood+components/pm30808637-181-15-7
Average 90 stars, based on 1 article reviews
To Manufacture Pathogen Reduced Blood Components, supplied by Cerus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/to+manufacture+pathogen+reduced+blood+components/to+manufacture+pathogen+reduced+blood+components/pm30808637-181-15-7
Average 90 stars, based on 1 article reviews
to manufacture pathogen reduced blood components - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Prevention of transfusion-transmitted infections. Article Snippet: (249/250 words) Since the 1970s, introduction of serological assays targeting virus-specific antibodies and antigens has been effective in identifying blood donations infected with the classic transfusion-transmitted infectious (TTI) agents (HBV, HIV, HTLV-I/II, HCV).. Subsequently, progressive implementation of nucleic acid-amplification technology (NAT) screening for HIV, HCV, and HBV has reduced the residual risk of infectious window period donations, such that per unit risks are <1 in 1,000,000 in the US, other high-income countries, and in high incidence regions performing NAT.. NAT screening has emerged as the preferred option for detection of newer TTI agents including West Nile virus, Zika virus, and Babesia microti. |